http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108478784-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
filingDate 2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108478784-B
titleOfInvention A kind of pharmaceutical composition containing thymalfasin
abstract The invention discloses a kind of pharmaceutical compositions containing thymalfasin, described pharmaceutical composition includes the thymalfasin and pharmaceutically acceptable high molecular material that weight ratio is 1:1-3, by the way that ingredient is dissolved in water/trifluoracetic acid/methylene chloride mixed solvent, crystalization in supercritical fluid precipitation is prepared.Pharmaceutical composition disclosed in this invention containing thymalfasin, it is with good stability, it can store for a long time at room temperature;And by selecting appropriate constituent, solvent and crystalization in supercritical fluid condition, the thymalfasin pharmaceutical composition with specific rate of release, partial size can be obtained, different medication demands can be met, there is biggish application value.
priorityDate 2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451856157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21899381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553

Total number of triples: 32.